New Mexico Tumor Registry
Bibliography of Journal Articles

Sorted by year, from most recent to most distant
to reference page

2006:
           Weaver DL, Rosenberg RD, Barlow WE, Ichikawa L, Carney PA, Kerlikowske K, Buist DS, Geller BM, Key CR, Maygarden SJ, Ballard-Barbash R. Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography. Cancer 2006;106:732-42.
            Wayne SJ, Baumgartner K, Baumgartner RN, Bernstein L, Bowen DJ, Ballard-Barbash R. Diet quality is directly associated with quality of life in breast cancer survivors. Breast Cancer Res. Treat. 2006;96:227-32.
            Smith HO, Berwick M, Verschraegen CF, Wiggins C, Lansing L, Muller CY, Qualls CR. Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol 2006;107:1075-85.
            Slattery ML, Sweeney C, Wolff R, Herrick J, Baumgartner K, Giuliano A, Byers T. Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States. Breast Cancer Res. Treat. 2006.
            Slattery ML, Sweeney C, Herrick J, Wolff R, Baumgartner K, Giuliano A, Byers T. ESR1, AR, body size, and breast cancer risk in Hispanic and non-Hispanic white women living in the Southwestern United States. Breast Cancer Res. Treat. 2006.
            Slattery ML, Sweeney C, Edwards S, Herrick J, Baumgartner K, Wolff R, Murtaugh M, Baumgartner R, Giuliano A, Byers T. Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women. Breast Cancer Res. Treat. 2006.
            Kelly JJ, Lanier AP, Alberts S, Wiggins CL. Differences in cancer incidence among Indians in Alaska and New Mexico and U.S. Whites, 1993-2002. Cancer Epidemiol. Biomarkers Prev. 2006;15:1515-9.
            Irwin ML, Aiello EJ, McTiernan A, Baumgartner RN, Baumgartner KB, Bernstein L, Gilliland FD, Ballard-Barbash R. Pre-diagnosis physical activity and mammographic density in breast cancer survivors. Breast Cancer Res. Treat. 2006;95:171-8.
            Hoffman RM, Barry MJ, Stanford JL, Hamilton AS, Hunt WC, Collins MM. Health outcomes in older men with localized prostate cancer: results from the Prostate Cancer Outcomes Study. Am. J. Med. 2006;119:418-25.
            Fordyce CA, Heaphy CM, Bisoffi M, Wyaco JL, Joste NE, Mangalik A, Baumgartner KB, Baumgartner RN, Hunt WC, Griffith JK. Telomere content correlates with stage and prognosis in breast cancer. Breast Cancer Res. Treat. 2006;99:193-202.
            Fan J, McKean-Cowdin R, Bernstein L, Stanczyk FZ, Li AX, Ballard-Barbash R, McTiernan A, Baumgartner R, Gilliland F. An association between a common variant (G972R) in the IRS-1 gene and sex hormone levels in post-menopausal breast cancer survivors. Breast Cancer Res. Treat. 2006;99:323-31.
            Du XL, Key CR, Dickie L, Darling R, Geraci JM, Zhang D. External validation of medicare claims for breast cancer chemotherapy compared with medical chart reviews. Med. Care 2006;44:124-31.
            Du XL, Key CR, Dickie L, Darling R, Delclos GL, Waller K, Zhang D. Information on chemotherapy and hormone therapy from tumor registry had moderate agreement with chart reviews. J Clin Epidemiol 2006;59:53-60.
            Berwick M, Wiggins C. The current epidemiology of cutaneous malignant melanoma. Front. Biosci. 2006;11:1244-54.
            Barlow WE, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff L, Carney PA, Tice JA, Buist DS, Geller BM, Rosenberg R, Yankaskas BC, Kerlikowske K. Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst 2006;98:1204-14.
            Alfano CM, McGregor BA, Kuniyuki A, Reeve BB, Bowen DJ, Wilder Smith A, Baumgartner KB, Bernstein L, Ballard-Barbash R, Malone KE, Ganz PA, McTiernan A. Psychometric evaluation of the Brief Cancer Impact Assessment among breast cancer survivors. Oncology 2006;70:190-202.
            Alfano CM, McGregor BA, Kuniyuki A, Reeve BB, Bowen DJ, Baumgartner KB, Bernstein L, Ballard-Barbash R, Malone KE, Ganz PA, McTiernan A. Psychometric properties of a tool for measuring hormone-related symptoms in breast cancer survivors. Psychooncology. 2006;15:985-1000.
            Abrahamson PE, Tworoger SS, Aiello EJ, Bernstein L, Ulrich CM, Gilliland FD, Stanczyk FZ, Baumgartner R, Baumgartner K, Sorensen B, Ballard-Barbash R, McTiernan A. Associations between the CYP17, CYPIB1, COMT and SHBG polymorphisms and serum sex hormones in post-menopausal breast cancer survivors. Breast Cancer Res. Treat. 2006.

2005:
            Wiggins CL, Berwick M, Bishop JA. Malignant melanoma in pregnancy. Obstet. Gynecol. Clin. North Am. 2005;32:559-68.
            Warren JL, Weaver DL, Bocklage T, Key CR, Platz CE, Cronin KA, Ballard-Barbash R, Willey SC, Harlan LC. The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis. Cancer 2005;104:1840-8.
            Stephenson RA, Mori M, Hsieh YC, Beer TM, Stanford JL, Gilliland FD, Hoffman RM, Potosky AL. Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the Surveillance, Epidemiology, and End Results Prostate Cancer Outcomes Study. J Urol 2005;174:646-50; discussion 50.
            Penson DF, McLerran D, Feng Z, Li L, Albertsen PC, Gilliland FD, Hamilton A, Hoffman RM, Stephenson RA, Potosky AL, Stanford JL. 5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study. J Urol 2005;173:1701-5.
            Irwin ML, McTiernan A, Bernstein L, Gilliland FD, Baumgartner R, Baumgartner K, Ballard-Barbash R. Relationship of obesity and physical activity with C-peptide, leptin, and insulin-like growth factors in breast cancer survivors. Cancer Epidemiol. Biomarkers Prev. 2005;14:2881-8.
            Irwin ML, McTiernan A, Baumgartner RN, Baumgartner KB, Bernstein L, Gilliland FD, Ballard-Barbash R. Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. J. Clin. Oncol. 2005;23:774-82.
            Hoffman RM, Stone SN, Herman C, Jung AM, Cotner J, Espey D, Kozoll R, Gavin MW. New Mexico's capacity for increasing the prevalence of colorectal cancer screening with screening colonoscopies. Preventing chronic disease 2005;2:A07.
            Hoffman RM, Stone SN, Espey D, Potosky AL. Differences between men with screening-detected versus clinically diagnosed prostate cancers in the USA. BMC Cancer 2005;5:27.
            Goodman MT, Hernandez BY, Hewitt S, Lynch CF, Cote TR, Frierson HF, Jr., Moskaluk CA, Killeen JL, Cozen W, Key CR, Clegg L, Reichman M, et al. Tissues from population-based cancer registries: a novel approach to increasing research potential. Hum Pathol 2005;36:812-20.

2004:
            White E, Miglioretti DL, Yankaskas BC, Geller BM, Rosenberg RD, Kerlikowske K, Saba L, Vacek PM, Carney PA, Buist DS, Oestreicher N, Barlow W, et al. Biennial versus annual mammography and the risk of late-stage breast cancer. J Natl Cancer Inst 2004;96:1832-9.
            Wayne SJ, Lopez ST, Butler LM, Baumgartner KB, Baumgartner RN, Ballard-Barbash R. Changes in dietary intake after diagnosis of breast cancer. J. Am. Diet. Assoc. 2004;104:1561-8.
            Smith HO, Qualls CR, Hilgers RD, Verschraegen CF, Rayburn WF, Cole LW, Padilla LA, Key CR. Gestational trophoblastic neoplasia in American Indians. J. Reprod. Med. 2004;49:535-44.
            Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, Harlan LC. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst 2004;96:1358-67.
            Irwin ML, McTiernan A, Bernstein L, Gilliland FD, Baumgartner R, Baumgartner K, Ballard-Barbash R. Physical activity levels among breast cancer survivors. Med. Sci. Sports Exerc. 2004;36:1484-91.
            Hoffman RM, MacDonald R, Wilt TJ. Laser prostatectomy for benign prostatic obstruction. Cochrane Database Syst Rev 2004:CD001987.
            Hoffman RM, Adams-Cameron ML, Murata GH. Misclassifying the indications for prostate-specific antigen testing may bias case-control studies of the efficacy of prostate cancer screening. J Clin Epidemiol 2004;57:1071-5.
            Hoffman R, Gilliland F, Penson DF, Stone N, Hunt C, Potosky A. Cross-sectional and longitudinal comparisions of health-related quality of life between patients with prostate carcinoma and matched controls. Cancer 2004;101:
2011-9.
            Du XL, Key CR, Osborne C. Community-based assessment of adjuvant hormone therapy in women with breast cancer, 1991-1997. Breast J 2004;10:433-9.
            Baumgartner K, Hunt C, Baumgartner R, Crumley D, Gilliland F, McTiernan A, Bernstein L, Ballard-Barbash R. Association of body composition and weight history with breast cancer prognositc markers: divergent pattern for Hispanic and non Hispanic white women. Am J Epidemiol 2004;160:1087-97.

2003:
            Stone SN, Hoffman RM, Tollestrup K, Stidley CA, Witter JL, Gilliland FD. Family history, Hispanic ethnicity, and prostate cancer risk. Ethn. Dis. 2003;13:233-9.
            Smith HO, Hilgers RD, Bedrick EJ, Qualls CR, Wiggins CL, Rayburn WF, Waxman AG, Stephens ND, Cole LW, Swanson M, Key CR. Ethnic differences at risk for gestational trophoblastic disease in New Mexico: A 25-year population-based study. Am J Obstet Gynecol 2003;188:357-66.
            Penson DF, Feng Z, Kuniyuki A, McClerran D, Albertsen PC, Deapen D, Gilliland F, Hoffman R, Stephenson RA, Potosky AL, Stanford JL. General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study. J. Clin. Oncol. 2003;21:1147-54.
            McTiernan A, Rajan KB, Tworoger SS, Irwin M, Bernstein L, Baumgartner R, Gilliland F, Stanczyk FZ, Yasui Y, Ballard-Barbash R. Adiposity and sex hormones in postmenopausal breast cancer survivors. J. Clin. Oncol. 2003;21:1961-6.
            Lanier AP, Holck P, Ehrsam Day G, Key C. Childhood cancer among Alaska Natives. Pediatrics 2003;112:e396.
            Irwin ML, Crumley D, McTiernan A, Bernstein L, Baumgartner R, Gilliland FD, Kriska A, Ballard-Barbash R. Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity, and Lifestyle (HEAL) study. Cancer 2003;97:1746-57.
            Hoffman RM, Stone SN, Hunt WC, Key CR, Gilliland FD. Effects of misattribution in assigning cause of death on prostate cancer mortality rates. Ann Epidemiol 2003;13:450-4.
            Hoffman RM, MacDonald R, Slaton JW, Wilt TJ. Laser prostatectomy versus transurethral resection for treating benign prostatic obstruction: a systematic review. J Urol 2003;169:210-5.
            Hoffman RM, Hunt WC, Gilliland FD, Stephenson RA, Potosky AL. Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study. Cancer 2003;97:1653-62.
            Hoffman RM, Harlan LC, Klabunde CN, Gilliland FD, Stephenson RA, Hunt WC, Potosky AL. Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study. J. Gen. Intern. Med. 2003;18:845-53.
            Hoffman RM. An argument against routine prostate cancer screening. Arch Intern Med 2003;163:663-5; discussion 5-6.
            Hoffman R, Stone N, Hunt C, Gilliland F. Quality of life changes in men with localized prostate cancer versus controls. J Gen Internal Med 2003;18:284.
            Geller BM, Kerlikowske K, Carney PA, Abraham LA, Yankaskas BC, Taplin SH, Ballard-Barbash R, Dignan MB, Rosenberg R, Urban N, Barlow WE. Mammography surveillance following breast cancer. Breast Cancer Res. Treat. 2003;81:107-15.
            Du XL, Key CR, Osborne C, Mahnken JD, Goodwin JS. Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer. Ann Intern Med 2003;138:90-7.
            Athas WF, Hunt WC, Key CR. Changes in nonmelanoma skin cancer incidence between 1977-1978 and 1998-1999 in Northcentral New Mexico. Cancer Epidemiol. Biomarkers Prev. 2003;12:1105-8.

2002:
            Wenten M, Gilliland FD, Baumgartner K, Samet JM. Associations of weight, weight change, and body mass with breast cancer risk in Hispanic and non-Hispanic white women. Ann Epidemiol 2002;12:435-4.
            Smith HO, Qualls CR, Romero AA, Webb JC, Dorin MH, Padilla LA, Key CR. Is there a difference in survival for IA1 and IA2 adenocarcinoma of the uterine cervix? Gynecol Oncol 2002;85:229-41.
            Potosky AL, Reeve BB, Clegg LX, Hoffman RM, Stephenson RA, Albertsen PC, Gilliland FD, Stanford JL. Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy. J Natl Cancer Inst 2002;94:430-7.
            Potosky A, Reeve BB, Clegg LX, Hoffman R, Stephenson RA, Albertsen P, Gilliland F, Stanford JL. Treatment and outcomes among men managed without surgery or radiotherapy for localized prostate cancer: results from The Prostate Cancer Outcomes Study. J Natl Cancer Inst 2002;94:430-7.
            Li R, Gilliland F, Baumgartner K, Samet J. Hormone replacement therapy and breast cancer risk in Hispanic and non-Hispanic white women, the New Mexico Women's Health Study. Cancer 2002;95:960-8.
            Hoffman RM, Gilliland FD, Adams-Cameron M, Hunt WC, Key CR. Prostate-specific antigen testing accuracy in community practice. BMC Fam Pract 2002;3:19.
            Hoffman RM, Clanon DL, Chavez M, Peirce JC. Using multiple cutpoints for the free-to-total prostate specific antigen ratio improves the accuracy of prostate cancer detection. Prostate 2002;52:150-8.
            Escobedo LG, Zhong Z, Key C. Breast and cervical cancer screening and disease incidence and stage in New Mexico. Cancer Causes Control 2002;13:137-45.
            Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, Yankaskas BC, Rosenberg R, Carney PA, Kerlikowske K, Taplin SH, Urban N, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 2002;94:1546-54.
            El-Serag HB, Mason AC, Petersen N, Key CR. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut 2002;50:368-72.
            Baumgartner KB, Annegers JF, McPherson RS, Frankowski RF, Gilliland FD, Samet JM. Is alcohol intake associated with breast cancer in Hispanic women? The New Mexico Women's Health Study. Ethn. Dis. 2002;12:460-9.
            Barlow WE, Lehman CD, Zheng Y, Ballard-Barbash R, Yankaskas BC, Cutter GR, Carney PA, Geller BM, Rosenberg R, Kerlikowske K, Weaver DL, Taplin SH. Performance of diagnostic mammography for women with signs or symptoms of breast cancer. J Natl Cancer Inst 2002;94:1151-9.

2001:
            Webb JC, Key CR, Qualls CR, Smith HO. Population-based study of microinvasive adenocarcinoma of the uterine cervix. Obstet Gynecol 2001;97:701-6.
            Schiff MA, Patterson RE, Baumgartner RN, Masuk M, van Asselt-King L, Wheeler CM, Becker TM. Serum carotenoids and risk of cervical intraepithelial neoplasia in Southwestern American Indian women. Cancer Epidemiol. Biomarkers Prev. 2001;10:1219-22.
            Potosky AL, Knopf K, Clegg LX, Albertsen PC, Stanford JL, Hamilton AS, Gilliland FD, Eley JW, Stephenson RA, Hoffman RM. Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study. J. Clin. Oncol. 2001;19:3750-7.
            Li R, Gilliland FD, Baumgartner KB, Samet J. Family history and risk of breast cancer in hispanic and non-hispanic women: the New Mexico Women's Health Study. Cancer Causes Control 2001;12:747-53.
            Hoffman RM, Gilliland FD, Eley JW, Harlan LC, Stephenson RA, Stanford JL, Albertson PC, Hamilton AS, Hunt WC, Potosky AL. Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst 2001;93:388-95.
            Harlan LC, Potosky A, Gilliland FD, Hoffman R, Albertsen PC, Hamilton AS, Eley JW, Stanford JL, Stephenson RA. Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study. J Natl Cancer Inst 2001;93:1864-71.
            Hamilton AS, Stanford JL, Gilliland FD, Albertsen PC, Stephenson RA, Hoffman RM, Eley JW, Harlan LC, Potosky AL. Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: results from the Prostate Cancer Outcomes Study. J. Clin. Oncol. 2001;19:2517-26.
            Gilliland FD, Li YF, Baumgartner K, Crumley D, Samet JM. Physical activity and breast cancer risk in hispanic and non-hispanic white women. Am J Epidemiol 2001;154:442-50.
            Gilliland FD, Gleason DF, Hunt WC, Stone N, Harlan LC, Key CR. Trends in Gleason score for prostate cancer diagnosed between 1983 and 1993. J Urol 2001;165:846-50.
            El-Serag HB, Mason AC, Key C. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology 2001;33:62-5.
            Clegg LX, Potosky AL, Harlan LC, Hankey BF, Hoffman RM, Stanford JL, Hamilton AS. Comparison of self-reported initial treatment with medical records: results from the prostate cancer outcomes study. Am J Epidemiol 2001;154:
582-7.

2000:
            Temes R, Allen N, Chavez T, Crowell R, Key C, Wernly J. Primary mediastinal malignancies in children: report of 22 patients and comparison to 197 adults. Oncologist 2000;5:179-84.
            Stanford JL, Feng Z, Hamilton AS, Gilliland FD, Stephenson RA, Eley JW, Albertsen PC, Harlan LC, Potosky AL. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA 2000;283:354-60.
            Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study. Gynecol Oncol 2000;78:97-105.
            Potosky AL, Legler J, Albertsen PC, Stanford JL, Gilliland FD, Hamilton AS, Eley JW, Stephenson RA, Harlan LC. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst 2000;92:1582-92.
            Legler J, Potosky AL, Gilliland FD, Eley JW, Stanford JL. Validation study of retrospective recall of disease-targeted function: results from the prostate cancer outcomes study. Med. Care 2000;38:847-57.
            Kerlikowske K, Carney PA, Geller B, Mandelson MT, Taplin SH, Malvin K, Ernster V, Urban N, Cutter G, Rosenberg R, Ballard-Barbash R. Performance of screening mammography among women with and without a first-degree relative with breast cancer. Ann Intern Med 2000;133:855-63.
            Hoffman RM, Clanon DL, Littenberg B, Frank JJ, Peirce JC. Using the free-to-total prostate-specific antigen ratio to detect prostate cancer in men with nonspecific elevations of prostate-specific antigen levels. J. Gen. Intern. Med. 2000;15:739-48.
            Hoffman R, Stone SN, Hunt WC, Gilliland F, Key C. Attribution bias in death certificate for men with prostate cancer: 1985-1995. J Investigative Med 2000;48:243.
            Hoffman R, Adams-Cameron M, Hunt WC, Key C, Gilliland F. Prostate-specific antigen testing in a community-based population:  Diagnostic performance and outcomes. J Investigative Med 2000;48:244.
            Gilliland FD, Joste N, Stauber PM, Hunt WC, Rosenberg R, Redlich G, Key CR. Biologic characteristics of interval and screen-detected breast cancers. J Natl Cancer Inst 2000;92:743-9.
            Gilliland FD, Hunt WC, Pardilla M, Key CR. Uranium mining and lung cancer among Navajo men in New Mexico and Arizona, 1969 to 1993. J Occup Environ Med 2000;42:278-83.
            Chao A, Gilliland F, Willman C, Joste N, Chen IM, Stone N, Ruschulte J, Viswanatha D, Duncan P, Ming R, Hoffman R, Foucar E, et al. Patient and tumor characteristics of colon cancers with microsatellite instability: a population-based study. Cancer Epidemiol. Biomarkers Prev. 2000;9:539-44.
            Athas WF, Adams-Cameron M, Hunt WC, Amir-Fazli A, Key CR. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst 2000;92:269-71.
            Albertsen PC, Hanley JA, Harlan LC, Gilliland FD, Hamilton A, Liff JM, Stanford JL, Stephenson RA. The positive yield of imaging studies in the evaluation of men with newly diagnosed prostate cancer: a population based analysis. J Urol 2000;163:1138-43.

1999:
            Temes R, Chavez T, Mapel D, Ketai L, Crowell R, Key C, Follis F, Pett S, Wernly J. Primary mediastinal malignancies: findings in 219 patients. West J Med 1999;170:161-6.
            Rosenblatt K, Thomas D, Jimenez LM, Fish B, McTiernan A, Stalsberg H, Stemhagen A, Thompson WD, Curnen MG, Satariano W, Austin D, Greenberg R, et al. The relationship between diet and breast cancer in men (United States). Cancer Causes Control 1999;10:107-13.
            Potosky AL, Harlan LC, Stanford JL, Gilliland FD, Hamilton AS, Albertsen PC, Eley JW, Liff JM, Deapen D, Stephenson RA, Legler J, Ferrans CE, et al. Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study. J Natl Cancer Inst 1999;91:1719-24.
            Hoffman RM, Gilliland FD. A population-based survey of prostate cancer testing in New Mexico. J. Community Health 1999;24:409-19.
            Herman CJ, Hoffman RM, Altobelli KK. Variation in recommendations for cancer screening among primary care physicians in New Mexico. J. Community Health 1999;24:253-67.
            Griffith JK, Bryant JE, Fordyce CA, Gilliland FD, Joste NE, Moyzis RK. Reduced telomere DNA content is correlated with genomic instability and metastasis in invasive human breast carcinoma. Breast Cancer Res. Treat. 1999;54:59-64.
            Gilliland FD, Hoffman RM, Hamilton A, Albertsen P, Eley JW, Harlan L, Stanford JL, Hunt WC, Potosky A, Stephenson RA. Predicting extracapsular extension of prostate cancer in men treated with radical prostatectomy: results from the population based prostate cancer outcomes study. J Urol 1999;162:1341-5.
            Eriksson A, Herron JR, Yamada T, Wheeler CM. Human papillomavirus type 16 variant lineages characterized by nucleotide sequence analysis of the E5 coding segment and the E2 hinge region. J. Gen. Virol. 1999;80 ( Pt 3):595-600.
            Adams-Cameron M, Gilliland FD, Hunt WC, Key CR. Trends in incidence and treatment for ductal carcinoma in situ in Hispanic, American Indian, and non-Hispanic white women in New Mexico, 1973-1994. Cancer 1999;85:1084-90.

1998:
            Peirce JC, Hoffman RM. Free PSA for detecting prostate cancer. JAMA 1998;280:1825-6.
            Morris DM, Boyle PJ, Stidley CA, Altobelli KK, Parnell T, Key C. Localized well-differentiated thyroid carcinoma: survival analysis of prognostic factors and (131)I therapy. Ann Surg Oncol 1998;5:329-37.
            Kulldorff M, Athas WF, Feurer EJ, Miller BA, Key CR. Evaluating cluster alarms: a space-time scan statistic and brain cancer in Los Alamos, New Mexico. Am J Public Health 1998;88:1377-80.
            Hoffman RM, Blume P, Gilliland F. Prostate-specific antigen testing practices and outcomes. J. Gen. Intern. Med. 1998;13:106-10.
            Gilliland FD, Key CR. Prostate cancer in American Indians, New Mexico, 1969 to 1994. J Urol 1998;159:893-7; discussion 7-8.
            Gilliland FD, Hunt WC, Key CR. Trends in the survival of American Indian, Hispanic, and Non-Hispanic white cancer patients in New Mexico and Arizona, 1969-1994. Cancer 1998;82:1769-83.
            Gilliland FD, Hunt WC, Baumgartner KB, Crumley D, Nicholson CS, Fetherolf J, Samet JM. Reproductive risk factors for breast cancer in Hispanic and non-Hispanic white women: the New Mexico Women's Health Study. Am J Epidemiol 1998;148:683-92.
            Gilliland F, Chao A, Crumley D, Samet J, Hunt WM. Physical activity and breast cancer risk in Hispanic and non-Hispanic white women, the New Mexico Women's Health Study. Am J Epidemiol 1998;147:39.
            Crumley D, Gilliland F, Ballard-Barbash R, Chao A, Hunt WC, Baumgartner R. Vigorous physical activity and breast cancer stage at diagnosis:  The New Mexico Women's Health Study. Am J Epidemiol 1998;147:23.
            Chao A, Gilliland FD, Hunt WC, Bulterys M, Becker TM, Key CR. Increasing incidence of colon and rectal cancer among Hispanics and American Indians in New Mexico (United States), 1969-94. Cancer Causes Control 1998;9:137-44.
            Chao A, Gilliland F, Joste N, Visnawatha D, Willman C, Key C. A population-based study of microsatellite instability in colon cancer. Am J Epidemiol 1998;147:28.
            Baumgartner KB, Gilliland FD, Nicholson CS, McPherson RS, Hunt WC, Pathak DR, Samet JM. Validity and reproducibility of a food frequency questionnaire among Hispanic and non-Hispanic white women in New Mexico. Ethn. Dis. 1998;8:81-92.

1997:
            Schiff M, Key CR, Gilliland FD, Becker TM. Ethnic differences in uterine corpus cancer incidence and mortality in New Mexico's American Indians, hispanics and non-Hispanic whites. Int J Epidemiol 1997;26:249-55.
            Peirce JC, Hoffman RM, Clanon DL. PSA thresholds for prostate cancer detection. JAMA 1997;278:700; author reply -1.
            Ming R, Weiss B, Deflice J, Blessing L, Gilliland F, Chao A. First-degree relatives of patients with colon cancer have a high incidence of colorectal adenomas. Gastroenterol 1997;112:A616.
            Hoffman R, Herman CJ, Gilliland F. Practice variation for colorectal and prostate cancer screening among primary care physicians in New Mexico. JGIM 1997;12:109.
            Gilliland FD, Larson M, Chao A. Risk factor information found in medical records of lung and prostate cancer cases, New Mexico Tumor Registry (United States). Cancer Causes Control 1997;8:598-604.
            Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer 1997;79:564-73.
            Ballard-Barbash R, Taplin SH, Yankaskas BC, Ernster VL, Rosenberg RD, Carney PA, Barlow WE, Geller BM, Kerlikowske K, Edwards BK, Lynch CF, Urban N, et al. Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol 1997;169:1001-8.

1996:
            Schiff M, Becker TM, Smith HO, Gilliland FD, Key CR. Ovarian cancer incidence and mortality in American Indian, Hispanic, and non-Hispanic white women in New Mexico. Cancer Epidemiol. Biomarkers Prev. 1996;5:323-7.
            Lanier AP, Kelly JJ, Smith B, Harpster AP, Tanttila H, Amadon C, Beckworth D, Key C, Davidson AM. Alaska Native cancer update: incidence rates 1989-1993. Cancer Epidemiol. Biomarkers Prev. 1996;5:749-51.
            Lambert WE, Davidson AM. Changing trends in skin cancer in New Mexico. J Registry Manage 1996;23:38-45.
            Gruber SB, Thompson WD, Rubin GL, Wingo PA, Lee NC, Mandel G, Peterson HB, Greenberg R, Meigs JW, Swanson GM, Smith E, Key C, et al. A population-based study of endometrial cancer and familial risk in younger women. Cancer Epidemiol. Biomarkers Prev. 1996;5:411-7.
            Gilliland FD, Hunt WC, Key CR. Ethnic variation in prostate cancer survival in New Mexico. Cancer Epidemiol. Biomarkers Prev. 1996;5:247-51.
            Gilliland FD, Hunt WC, Key CR. Improving survival for patients with prostate cancer diagnosed in the prostate-specific antigen ERA. Urology 1996;48:67-71.
            Frost F, Tollestrup K, Hunt WC, Gilliland F, Key CR, Urbina CE. Breast cancer survival among New Mexico Hispanic, American Indian, and non-Hispanic white women (1973-1992). Cancer Epidemiol. Biomarkers Prev. 1996;5:861-6.
            Chao A, Becker TM, Jordan SW, Darling R, Gilliland FD, Key CR. Decreasing rates of cervical cancer among American Indians and Hispanics in New Mexico (United States). Cancer Causes Control 1996;7:205-13.

1995:
            Gilliland FD, Welsh DJ, Hoffman RM, Key CR. Rapid rise and subsequent decline in prostate cancer incidence rates for New Mexico, 1989-1993. Cancer Epidemiol. Biomarkers Prev. 1995;4:797-800.
            Gilliland FD, Key CR. Male genital cancers. Cancer 1995;75:295-315.
            Bartow SA, Pathak DR, Mettler FA, Key CR, Pike MC. Breast mammographic pattern: a concatenation of confounding and breast cancer risk factors. Am J Epidemiol 1995;142:813-9.

1994:
            Thomas DB, Rosenblatt K, Jimenez LM, McTiernan A, Stalsberg H, Stemhagen A, Thompson WD, Curnen MG, Satariano W, Austin DF, et al. Ionizing radiation and breast cancer in men (United States). Cancer Causes Control 1994;5:9-14.
            Lanier AP, Kelly JJ, Smith B, Amadon C, Harpster A, Peters H, Tanttila H, Key C, Davidson AM. Cancer in the Alaska Native population: Eskimo, Aleut, and Indian. Incidence and trends 1969-1988. Alaska Med 1994;36:3-92.
            Gilliland FD, Samet JM. Lung cancer. Cancer Surv. 1994;19-20:175-95.
            Gilliland FD, Becker TM, Key CR, Samet JM. Contrasting trends of prostate cancer incidence and mortality in New Mexico's Hispanics, non-Hispanic whites, American Indians, and blacks. Cancer 1994;73:2192-9.
            Gilliland F, Becker TM, Smith A, Key CR, Samet JM. Trends in prostate cancer incidence and mortality in New Mexico are consistent with an increase in effective screening. Cancer Epidemiol. Biomarkers Prev. 1994;3:105-11.
            Eidson M, Becker TM, Wiggins CL, Key CR, Samet JM. Breast cancer among Hispanics, American Indians and non-Hispanic whites in New Mexico. Int J Epidemiol 1994;23:231-7.
            Becker TM, Wheeler CM, McGough NS, Parmenter CA, Jordan SW, Stidley CA, McPherson RS, Dorin MH. Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern Hispanic and non-Hispanic white women. JAMA 1994;271:1181-8.

1993:
            Wiggins CL, Becker TM, Key CR, Samet JM. Cancer mortality among New Mexico's Hispanics, American Indians, and non-Hispanic Whites, 1958-1987. J Natl Cancer Inst 1993;85:1670-8.
            Swanson GM, Ragheb NE, Lin C-S, Hankey BF, Miller BA, Hom-Ross P, White E, Liff JM, Harlan L, McWhorter WP, Mullan PB, Key C. Breast cancer among Black and White women in the 1980s.  Changing patterns in the United States by race, age, and extent of disease. Cancer 1993;72:788-98.
            Stalsberg H, Thomas DB, Rosenblatt KA, Jimenez LM, McTiernan A, Stemhagen A, Thompson WD, Curnen MG, Satariano W, Austin DF, et al. Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States men. Cancer Causes Control 1993;4:143-51.

1992:
            Thomas DB, Jimenez LM, McTiernan A, Rosenblatt K, Stalsberg H, Stemhagen A, Thompson WD, Curnen MG, Satariano W, Austin DF, et al. Breast cancer in men: risk factors with hormonal implications. Am J Epidemiol 1992;135:734-48.
            Samet JM, Howard CA, Coultas DB, Skipper BJ. Acculturation, education, and income as determinants of cigarette smoking in New Mexico Hispanics. Cancer Epidemiol. Biomarkers Prev. 1992;1:235-40.
            Linver MN, Paster SB, Rosenberg RD, Key CR, Stidley CA, King WV. Improvement in mammography interpretation skills in a community radiology practice after dedicated teaching courses: 2-year medical audit of 38,633 cases. Radiology 1992;184:39-43.
            Farrow DC, Hunt WC, Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med 1992;326:1097-101.
            Becker TM, Wiggins CL, Key CR, Samet JM. Changing trends in mortality among New Mexico's American Indians, 1958-1987. Int J Epidemiol 1992;21:690-700.
            Becker TM, Wheeler CM, Key CR, Samet JM. Cervical cancer incidence and mortality in New Mexico's Hispanics, American Indians, and non-Hispanic whites. West J Med 1992;156:376-9.

1991:
            Samet JM, Pathak DR, Morgan MV, Key CR, Valdivia AA, Lubin JH. Lung cancer mortality and exposure to radon progeny in a cohort of New Mexico underground uranium miners. Health Phys 1991;61:745-52.
            Rosenblatt KA, Thomas DB, McTiernan A, Austin MA, Stalsberg H, Stemhagen A, Thompson WD, Curnen MG, Satariano W, Austin DF, et al. Breast cancer in men: aspects of familial aggregation. J Natl Cancer Inst 1991;83:849-54.
            Pathak DR, Pike MC, Key CR, Teaf SR, Bartow SA. Parity factors and prevalence of fibrocystic breast change in a forensic autopsy series. Br J Cancer 1991;63:1005-9.
            Hjelle B, Mills R, Swenson S, Mertz G, Key C, Allen S. Incidence of hairy cell leukemia, mycosis fungoides, and chronic lymphocytic leukemia in first known HTLV-II-endemic population. J Infect Dis 1991;163:435-40.
            Goodwin JS, Hunt WC, Samet JM. A population-based study of functional status and social support networks of elderly patients newly diagnosed with cancer. Arch Intern Med 1991;151:366-70.
            Foucar K, Duncan MH, Stidley CA, Wiggins CL, Hunt WC, Key CR. Survival of children and adolescents with acute lymphoid leukemia. A study of American Indians and Hispanic and non-Hispanic whites treated in New Mexico (1969 to 1986). Cancer 1991;67:2125-30.
            Demers PA, Thomas DB, Rosenblatt KA, Jimenez LM, McTiernan A, Stalsberg H, Stemhagen A, Thompson WD, Curnen MG, Satariano W, et al. Occupational exposure to electromagnetic fields and breast cancer in men. Am J Epidemiol 1991;134:340-7.

1990:
            152. Samet JM, Hunt WC, Goodwin JS. Determinants of cancer stage. A population-based study of elderly New Mexicans. Cancer 1990;66:1302-7.
            153. Goodwin JS, Hunt WC, Key CR, Samet JM. Changes in surgical treatments: the example of hysterectomy versus conization for cervical carcinoma in situ. J Clin Epidemiol 1990;43:977-82.

1989-1980:
            Wiggins CL, Becker TM, Key CR, Samet JM. Stomach cancer among New Mexico's American Indians, Hispanic whites, and non-Hispanic whites. Cancer Res 1989;49:1595-9.
            Samet JM, Pathak DR, Morgan MV, Marbury MC, Key CR, Valdivia AA. Radon progeny exposure and lung cancer risk in New Mexico U miners: a case-control study. Health Phys 1989;56:415-21.
            Mones ID, Key C, Wheeler CM. Invasive cervical carcinoma in Native Americans of the Southwest:  HPV analysis by in situ hybridization. J. Cell. Biochem. 1989;13C:192.
            Becker TM, Goodwin JS, Hunt WC, Key CR, Samet JM. Survival after cancer surgery of elderly patients in New Mexico, 1969-1982. J Am Geriatr Soc 1989;37:155-9.
            Vaughn EA, Key CR, Sterling WA, Jr. Intraabdominal operations in patients with leukemia. Am J Surg 1988;156:51-3.
            Samet JM, Wiggins CL, Key CR, Becker TM. Mortality from lung cancer and chronic obstructive pulmonary disease in New Mexico, 1958-82. Am J Public Health 1988;78:1182-6.
            Samet JM, Wiggins CL, Humble CG, Pathak DR. Cigarette smoking and lung cancer in New Mexico. Am. Rev. Respir. Dis. 1988;137:1110-3.
            Samet JM, Hunt WC, Lerchen ML, Goodwin JS. Delay in seeking care for cancer symptoms: a population-based study of elderly New Mexicans. J Natl Cancer Inst 1988;80:432-8.
            Mann BA, Samet JM, Hunt WC, Key CR, Goodwin JM, Goodwin JS. Changing treatment of breast cancer in New Mexico from 1969 through 1985. JAMA 1988;259:3413-7.
            Goodwin JS, Hunt WC, Humble CG, Key CR, Samet JM. Cancer treatment protocols. Who gets chosen? Arch Intern Med 1988;148:2258-60.
            Samet JM, Key CR, Hunt WC, Goodwin JS. Survival of American Indian and Hispanic cancer patients in New Mexico and Arizona, 1969-82. J Natl Cancer Inst 1987;79:457-63.
            Samet JM, Key CR. Environmental epidemiology for pathologists. Hum Pathol 1987;18:886-94.
            Samet JM, Humble CG, Skipper BE, Pathak DR. History of residence and lung cancer risk in New Mexico. Am J Epidemiol 1987;125:800-11.
            Paganini-Hill A, Chao A, Ross RK, Henderson BE. Vitamin A, beta-carotene, and the risk of cancer: a prospective study. J Natl Cancer Inst 1987;79:443-8.
            McCulloch AW, Woodside JR, Lackner LH, Key C. Coexistence of prostate cancer and dysfunctional bladder neck obstruction. Neurourol. Urodyn. 1987;6:317-20.
            Lerchen ML, Wiggins CL, Samet JM. Lung cancer and occupation in New Mexico. J Natl Cancer Inst 1987;79:639-45.
            Humble CG, Samet JM, Pathak DR. Marriage to a smoker and lung cancer risk. Am J Public Health 1987;77:598-602.
            Humble C, Samet J, Skipper BE. Use of quantified and frequency indices of vitamin A intake in a case-control study of lung cancer. Int. J. Epidemiol. 1987;16:341-6.
            Hartge P, Silverman D, Hoover R, Schairer C, Altman R, Austin D, Cantor K, Child M, Key C, Marrett LD, et al. Changing cigarette habits and bladder cancer risk: a case-control study. J Natl Cancer Inst 1987;78:1119-25.
            Goodwin JS, Hunt WC, Key CR, Samet JM. The effect of marital status on stage, treatment, and survival of cancer patients. JAMA 1987;258:3125-30.
            Cantor KP, Hoover R, Hartge P, Mason TJ, Silverman DT, Altman R, Austin DF, Child MA, Key CR, Marrett LD, et al. Bladder cancer, drinking water source, and tap water consumption: a case-control study. J Natl Cancer Inst 1987;79:1269-79.
            Butler C, Samet JM, Humble CG, Sweeney ES. Histopathology of lung cancer in New Mexico, 1970-72 and 1980-81. J Natl Cancer Inst 1987;78:85-90.
            Bartow SA, Pathak DR, Black WC, Key CR, Teaf SR. Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study. Cancer 1987;60:2751-60.
            Samet JM, Humble CG, Pathak DR. Personal and family history of respiratory disease and lung cancer risk. Am. Rev. Respir. Dis. 1986;134:466-70.
            Samet J, Hunt WC, Key C, Humble CG, Goodwin JS. Choice of cancer therapy varies with age of patient. JAMA 1986;255:3385-90.
            Radi MJ, Fenoglio-Preiser CM, Bartow SA, Key CR, Pathak DR. Gastric carcinoma in the young: a clinicopathological and immunohistochemical study. Am J Gastroenterol 1986;81:747-56.
            Peters RK, Chao A, Mack TM, Thomas D, Bernstein L, Henderson BE. Increased frequency of adenocarcinoma of the uterine cervix in young women in Los Angeles County. J Natl Cancer Inst 1986;76:423-8.
            Pathak DR, Samet JM, Humble CG, Skipper BJ. Determinants of lung cancer risk in cigarette smokers in New Mexico. J Natl Cancer Inst 1986;76:597-604.
            Humble CG, Samet JM. Smoking and lung cancer in New Mexico. Am J Public Health 1986;76:1361.
            Goodwin JS, Samet JM, Key CR, Humble C, Kutvirt D, Hunt C. Stage at diagnosis of cancer varies with the age of the patient. J Am Geriatr Soc 1986;34:20-6.
            Duncan MH, Wiggins CL, Samet JM, Key CR. Childhood cancer epidemiology in New Mexico's American Indians, Hispanic whites, and non-Hispanic whites, 1970-82. J Natl Cancer Inst 1986;76:1013-8.
            Coultas DB, Samet JM, Wiggins CL, Butler C, Sweeney ES, Parzyck T. Clinical features of a population-based series of patients with lung cancer presenting with a solitary nodule. Am. Rev. Respir. Dis. 1986;133:302-6.
            Butler C, Samet JM, Black WC, Key CR, Kutvirt DM. Histopathologic findings of lung cancer in Navajo men: relationship to U mining. Health Phys 1986;51:365-8.
            Samet JM, Skipper BJ, Humble CG, Pathak DR. Lung cancer risk and vitamin A consumption in New Mexico. Am. Rev. Respir. Dis. 1985;131:198-202.
            Humble CG, Samet JM, Pathak DR, Skipper BJ. Cigarette smoking and lung cancer in 'Hispanic' whites and other whites in New Mexico. Am J Public Health 1985;75:145-8.
            Samet JM, Kutvirt DM, Waxweiler RJ, Key CR. Uranium mining and lung cancer in Navajo men. N Engl J Med 1984;310:1481-4.
            Acquavella JF, Wilkinson GS, Tietjen GL, Key CR, Stebbings JH, Voelz GL. A melanoma case-control study at the Los Alamos National Laboratory. Health Phys 1983;45:587-92.
            Pathak DR, Samet JM, Howard CA, Key CR. Malignant melanoma of the skin in New Mexico 1969-1977. Cancer 1982;50:1440-6.
            Jordan SW, Key CR, Wright DE. Selected characteristics of cervical cancer incidence cases. Acta Cytol 1982;26:823-32.
            Hartge P, Hoover R, Altman R, Austin D, Cantor K, Child M, Key C, Mason TJ, Marrett LD, Myers MH, Narayana AS, Silverman D, et al. Use of hair dyes and risk of bladder cancer. Cancer Res. 1982;42:4784-7.
            Acquavella JF, Tietjen GL, Wilkinson GS, Key CR, Voelz GL. Malignant melanoma incidence at the Los Alamos National Laboratory. Lancet 1982;1:883-4.
            Jordan SW, Key CR. Carcinoma of the cervix in Southwestern American indians: results of a cytologic detection program. Cancer 1981;47:2523-32.
            Samet JM, Key CR, Kutvirt DM, Wiggins CL. Respiratory disease mortality in New Mexico's American Indians and Hispanics. Am J Public Health 1980;70:492-7.
            Hoover RN, Strasser PH. Artificial sweeteners and human bladder cancer. Preliminary results. Lancet 1980;1:837-40.
            Black WC, Key CR. Epidemiologic pathology of cancer in New Mexico's tri-ethnic population. Pathol Annu 1980;15:181-94.

Pre-1980:
            Morris DL, Buechley RW, Key CR, Morgan MV. Gallbladder disease and gallbladder cancer among American Indians in tricultural New Mexico. Cancer 1978;42:2472-7.
            Bordin GM, Key CR, McQuade CE, Kutvirt DM, Hughes WB, Brylinski DA. Multiple primary cancers: relative risk in New Mexico's triethnic population. Cancer 1977;40:1793-800.
            Black WC, Key CR, Carmany TB, Herman D. Carcinoma of the gallbladder in a population of Southwestern American Indians. Cancer 1977;39:1267-79.
            Jordan SW, Sopher RL, Key CR, Brylinski D, Huang J. Carcinoma of the cervix in Southwestern American Indian women. Cancer 1972;29:1235-41.
            Key CR. Carcinoma of the thyroid. Hum Pathol 1971;2:521-3.
            Key CR. Carcinoma of the skin. Hum Pathol 1971;2:529-30.